Vradem

Vradem (Bosentan Monohydrate) is an endothelin receptor antagonist used to manage pulmonary arterial hypertension. This oral medication helps improve exercise capacity and symptoms in adult patients. Suitable for long-term therapy under medical supervision.

Vradem is primarily used to treat pulmonary arterial hypertension, a condition characterized by high blood pressure in the lungs. It may also be prescribed for other conditions as determined by a healthcare provider. Patients often ask, 'what is Vradem used for' to understand its role in managing vascular conditions.

Vradem works by blocking endothelin receptors, which helps relax blood vessels in the lungs and improve blood flow. Common effects include reduced breathlessness and improved energy levels during daily activities. Individual responses may vary based on medical history.

Vradem should be taken exactly as prescribed, typically with or without food. Regular liver function tests are recommended due to potential effects on liver enzymes. Avoid sudden discontinuation without consulting a healthcare provider to prevent adverse effects.

Vradem may interact with other medications, including CYP3A4 inhibitors and inducers, as well as drugs metabolized by the liver. Alcohol and grapefruit products may also affect its metabolism. Always inform your doctor about all medications and supplements you are taking.